Literature DB >> 24126842

Cell proliferation and expression of connexins differ in melanotic and amelanotic canine oral melanomas.

Tarso Felipe Teixeira1, Luciana Boffoni Gentile, Tereza Cristina da Silva, Gregory Mennecier, Lucas Martins Chaible, Bruno Cogliati, Marco Antonio Leon Roman, Marco Antonio Gioso, Maria Lucia Zaidan Dagli.   

Abstract

Melanoma is a malignant neoplasm occurring in several animal species, and is the most frequently found tumor in the oral cavity in dogs. Melanomas are classified into two types: melanotic and amelanotic. Prior research suggests that human amelanotic melanomas are more aggressive than their melanotic counterparts. This study evaluates the behavior of canine melanotic and amelanotic oral cavity melanomas and quantifies cell proliferation and the expression of connexins. Twenty-five melanomas (16 melanotic and 9 amelanotic) were collected from dogs during clinical procedures at the Veterinary Hospital of the School of Veterinary Medicine and Animal Science of the University of São Paulo, Brazil. After diagnosis, dogs were followed until death or euthanasia. Histopathology confirmed the gross melanotic or amelanotic characteristics and tumors were classified according to the WHO. HMB45 or Melan A immunostainings were performed to confirm the diagnosis of amelanotic melanomas. Cell proliferation was quantified both by counting mitotic figures and PCNA positive nuclei. Expressions of connexins 26 and 43 were evaluated by immunohistochemistry, qRT-PCR and Western blot. Dogs bearing amelanotic melanomas presented a shorter lifespan in comparison to those with melanotic melanomas. Cell proliferation was significantly higher in amelanotic melanomas. Expressions of Connexins 26 and 43 were significantly reduced in amelanotic melanomas. The results presented here suggest that oral cavity melanotic and amelanotic melanomas differ regarding their behavior, cell proliferation and connexin expression in dogs, indicating a higher aggressiveness of amelanotic variants.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24126842     DOI: 10.1007/s11259-013-9580-z

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  38 in total

Review 1.  Structural and functional diversity of connexin genes in the mouse and human genome.

Authors:  Klaus Willecke; Jürgen Eiberger; Joachim Degen; Dominik Eckardt; Alessandro Romualdi; Martin Güldenagel; Urban Deutsch; Goran Söhl
Journal:  Biol Chem       Date:  2002-05       Impact factor: 3.915

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

3.  Expression of connexins 26 and 43 in canine hyperplastic and neoplastic mammary glands.

Authors:  L N Torres; J M Matera; C H Vasconcellos; J L Avanzo; F J Hernandez-Blazquez; M L Z Dagli
Journal:  Vet Pathol       Date:  2005-09       Impact factor: 2.221

Review 4.  Role of connexin (gap junction) genes in cell growth control and carcinogenesis.

Authors:  H Yamasaki; V Krutovskikh; M Mesnil; T Tanaka; M L Zaidan-Dagli; Y Omori
Journal:  C R Acad Sci III       Date:  1999 Feb-Mar

Review 5.  Pigmentation in melanomas: changes manifesting underlying oncogenic and metabolic activities.

Authors:  Ruth Halaban
Journal:  Oncol Res       Date:  2002       Impact factor: 5.574

6.  Proliferation activity in oral and cutaneous canine melanocytic tumours: correlation with histological parameters, location, and clinical behaviour.

Authors:  F Millanta; F Fratini; M Corazza; M Castagnaro; V Zappulli; A Poli
Journal:  Res Vet Sci       Date:  2002-08       Impact factor: 2.534

Review 7.  Dynamics of cell interactions and communications during melanoma development.

Authors:  G Li; K Satyamoorthy; M Herlyn
Journal:  Crit Rev Oral Biol Med       Date:  2002

8.  Connexin 26 induces growth suppression, apoptosis and increased efficacy of doxorubicin in prostate cancer cells.

Authors:  Motoyoshi Tanaka; H Barton Grossman
Journal:  Oncol Rep       Date:  2004-02       Impact factor: 3.906

9.  Comparison of tyrosinase-related protein-2, S-100, and Melan A immunoreactivity in canine amelanotic melanomas.

Authors:  C Choi; D F Kusewitt
Journal:  Vet Pathol       Date:  2003-11       Impact factor: 2.221

10.  Oral malignant melanoma with osteoid formation in a dog.

Authors:  S Chénier; M Doré
Journal:  Vet Pathol       Date:  1999-01       Impact factor: 2.221

View more
  6 in total

1.  Undifferentiated sinonasal malignant melanoma: A case report.

Authors:  Jun Du; Liang-Liang Huang; Ao Xu; An-Li Zhang; Xue Kong; Min Ding; Wen Hu; Zhen-Li Guo; Wen Zhong; Si-Bai Sun; Heng Li; Jie Chen; Qian Shen; Lu-Lu Xu; Hai-Bo Wu
Journal:  Oncol Lett       Date:  2018-05-08       Impact factor: 2.967

2.  Exploring Differential Connexin Expression across Melanocytic Tumor Progression Involving the Tumor Microenvironment.

Authors:  Gergo Kiszner; Peter Balla; Barna Wichmann; Gabor Barna; Kornelia Baghy; Istvan Balazs Nemeth; Erika Varga; Istvan Furi; Bela Toth; Tibor Krenacs
Journal:  Cancers (Basel)       Date:  2019-02-01       Impact factor: 6.639

3.  Unraveling the Risk Factors and Etiology of the Canine Oral Mucosal Melanoma: Results of an Epidemiological Questionnaire, Oral Microbiome Analysis and Investigation of Papillomavirus Infection.

Authors:  Joyce Pires de Carvalho; Marcella Collaneri Carrilho; Denner Santos Dos Anjos; Carolina Dagli Hernandez; Laura Sichero; Maria Lúcia Zaidan Dagli
Journal:  Cancers (Basel)       Date:  2022-07-13       Impact factor: 6.575

4.  Effects of Alpha-Connexin Carboxyl-Terminal Peptide (aCT1) and Bowman-Birk Protease Inhibitor (BBI) on Canine Oral Mucosal Melanoma (OMM) Cells.

Authors:  Ayami Sato; Ivone Izabel Mackowiak da Fonseca; Márcia Kazumi Nagamine; Gabriela Fernandes de Toledo; Rennan Olio; Francisco Javier Hernandez-Blazquez; Tomohiro Yano; Elizabeth Shinmay Yeh; Maria Lucia Zaidan Dagli
Journal:  Front Vet Sci       Date:  2021-06-10

5.  Antitumor and antimetastatic activities of chloroform extract of medicinal mushroom Cordyceps taii in mouse models.

Authors:  Ru-Ming Liu; Xiao-Jie Zhang; Gui-You Liang; Yong-Fu Yang; Jian-Jiang Zhong; Jian-Hui Xiao
Journal:  BMC Complement Altern Med       Date:  2015-07-09       Impact factor: 3.659

Review 6.  Comparative Aspects of Canine Melanoma.

Authors:  Adriana Tomoko Nishiya; Cristina Oliveira Massoco; Claudia Ronca Felizzola; Eduardo Perlmann; Karen Batschinski; Marcello Vannucci Tedardi; Jéssica Soares Garcia; Priscila Pedra Mendonça; Tarso Felipe Teixeira; Maria Lucia Zaidan Dagli
Journal:  Vet Sci       Date:  2016-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.